Anika Therapeutics, Inc.

Anika Therapeutics, Inc.

Anika Therapeutics, Inc.

Date Founded



32 Wiggins Avenue, Bedford, MA, 01730, USA

Type of Company


Employees (Worldwide)



Industrial Machinery & Manufacturing
Medical Products & Equipment

Company Description

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

Contact Data
Trying to get in touch with decision makers at Anika Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Director, Human Resources

Executive Vice President of Human Resources

Interim General Manager

Vice President of Finance & Corporate Controller

Executive Vice President-Business Development & Strategic Planning

Vice President of Clinical Affairs

Vice President of Human Resources

Vice President-Quality, Regulatory & Clinical Affairs

Vice President Corporate Legal Counsel

Board of Directors

Baker Foundation Professor of Business Administration at Harvard University - Harvard Business School

Former Chairman at BioAmber, Inc.

Partner at HealthEdge Investment Partners LLC

President & Chief Executive Officer at Anika Therapeutics, Inc.

President & Chief Executive Officer at Keratin Biosciences, Inc.

Former Corporate Officer & President of the BioPharmaceutical Division at EMD Millipore Corporation

Co-Founder at Aquinnah Pharmaceuticals, Inc.

Paths to Anika Therapeutics, Inc.
Potential Connections via
Relationship Science
Anika Therapeutics, Inc.
Owners & Shareholders
Details Hidden

CWAM provides professional management of global equity assets using in-house resources to seek superior long term results. The firm follows a fundamental, research-intensive investment style characterized by unconventional stock picking and multi-year time horizon.CWAM's investment style can be best described as growth at a reasonable price (GARP). The firm seeks to buy growing, undervalued companies, grow with them, and sell them when their growth slows or when they believe they are fully valued. The firm is particularly interested in underfollowed stocks and niche companies. They like companies that benefit from long-term trends that CWAM identifies. The firm uses dividend discount, private market value and cash flow models to value stocks. CWAM especially likes companies with hidden values beyond reported EPS, such as unusually high free cash flow, masked earnings power or hidden assets. They usually avoid companies in highly competitive or unpredictable industries, such as airlines, commodity semiconductors and many natural resource areas. CWAM invests client assets in certain small to medium capitalization companies, both US and foreign, that it believes have growth potential, financial strength and fundamental value. Although the firm invests its managed assets primarily in equity securities, it may also invest in other types of securities.

Details Hidden

Matarin Capital Management employs a quantitative investment approach that seeks to generate superior risk-adjusted investment returns. The firm seeks to capitalize on the occasional mispricing of individual securities and broad asset classes that occurs in the capital markets.The firm's Market Neutral US Plus strategy seeks to outperform cash while minimizing stock market risk by investing both long and short in US equities. The strategy is designed to achieve annualized excess returns of 5% to 7% with a tracking error of 6% to 10%.Matarin Capital Management's North America Small-Cap strategy seeks to outperform the S&P 600 Index over a 3 to 5-year investment horizon. It is a long-only portfolio that holds and average of 100 positions selected from a universe of small-cap North American equities and is diversified across industries and sectors. The strategy is designed to achieve annualized excess returns of 2% to 4% with a tracking error of 3% to 6%.The firm's Global Markets Select strategy seeks to deliver absolute returns by making opportunistic long and short investments in stock indices, sovereign debt, money markets, currencies and commodities using global futures contracts. The strategy is designed to achieve annualized excess returns (above a cash benchmark) of 8% to 12% with a tracking error of 12% to 18%.

Details Hidden

Caption Management LLC is an American private company located in Oklahoma City, OK. The firm provides investment advice. It was founded in 2012 by Jason Sam Barnathan Strasser and William Lamble Cooper. William Lamble Cooper has been the CEO since that date.

Recent Transactions
Details Hidden

Anika Therapeutics, Inc. purchases Anika Therapeutics SRL from Fidia Farmaceutici SpA

Insider Transactions
Details Hidden
Advisors & Consultants

Former Chief Technology & Strategy Officer at Anika Therapeutics, Inc.


Former Chief Operating Officer at Anika Therapeutics, Inc.


Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Debt TEV
TEVNet Income
Enterprise Value EBITDAOperating
Enterprise Value Sales
Total Equity
Total Debt
Net Profit
Five Year Compounded Annual Growth Rate Of Revenue
Three Year Compounded Annual Growth Rate Of Revenue
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Anika Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Anika Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Anika Therapeutics, Inc..